Biogen
Phone: +1 781-464-2000
| Formerly | Biogen Idec Inc. (2003–2015) |
|---|---|
| Type | Public company |
| Traded as |
|
| Industry | Biotechnology |
| Founded | 1978 (1978) |
| Founders | Kenneth Murray Phillip Allen Sharp Walter Gilbert Heinz Schaller Charles Weissmann |
| Headquarters | Cambridge, Massachusetts, U.S. |
| Key people | Stelios Papadopoulos (Chairman) Michel Vounatsos (CEO) |
| Products | Avonex, Fampyra, Plegridy, Tecfidera, Tysabri, Spinraza |
| Revenue |  US$10.981 billion (2021) |
| Operating income | US$2.84 billion (2021) |
| Net income | US$1.727 billion (2021) |
| Total assets | US$23.877 billion (2021) |
| Total equity |  US$10.96 billion (2021) |
| Number of employees | 9,100 (2020) |
| Website | biogen.com |
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
For detailed contact information visit location pages below.
Biogen's locations around the world
Europe
North America
Oceania
Clinical Trials sponsored by Biogen
-
Biogen招聘中
-
Biogen招聘中肌肉萎缩，脊柱美国, 巴西, 中国, 日本, 澳大利亚
-
Biogen招聘中
-
Biogen主动，不招人多发性硬化症，复发缓解西班牙, 匈牙利, 德国, 澳大利亚, 比利时, 法国, 克罗地亚, 美国, 葡萄牙, 捷克语, 意大利, 保加利亚, 希腊, 以色列, 沙特阿拉伯, 塞尔维亚, 突尼斯, 土耳其（türkiye）, 科威特, 俄罗斯, 阿根廷, 斯洛伐克